✦ LIBER ✦

The clinical relevance of antibodies to ribosomal P—where are we now?

✍ Scribed by Fox, Robin A. ;Isenberg, David A.

Publisher: Informa UK (Informa Healthcare)
Year: 1997
Tongue: English
Weight: 575 KB
Volume: 7
Category: Article
ISSN: 0169-1163
DOI: 10.1007/bf03041326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should we forget the road that led to wh

Should we forget the road that led to where we are now?

✍ T. F. Molnar; L. Lukacs; O. P. Horvath 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 47 KB

Two decades of the public health approac

Two decades of the public health approach to skin cancer control in Australia: Why, how and where are we now?

✍ Robin Marks 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Incidence and mortality rates due to skin cancer are rising in most Western countries. Early detection of these tumours at a stage when they can be easily cured is the primary approach taken by many people wishing to deal with the problem. A primary prevention approach, that is, reduction in sunligh